Navigation Links
VSL#3®, Clinically-Studied Probiotic Kept Refrigerated Behind the Pharmacy Counter, Now Showing at Shelf with a Card, a First in the Probiotic Category
Date:8/7/2014

Gaithersburg, MD (PRWEB) August 07, 2014

Consumers have gotten used to seeing shelf cards in place of full product packages in certain categories of products, such as cold and flu, when either price or ingredients are deemed an issue for the store. Now, in an effort to offer consumers a different type of probiotic, one that is up to 10 times more potent than the average probiotic Sigma-Tau Pharmaceuticals, distributor of VSL#3® (http://www.vsl3.com), is introducing shelf cards for its VSL#3 line of live bacterial probiotics. The new cards will position VSL#3, a high-potency probiotic medical food for the dietary management of irritable bowel syndrome (IBS) and ulcerative colitis (UC) in adults, in the probiotic aisle, where many consumers go first when looking for an over-the-counter product.

Unlike most other commercially-available probiotics, VSL#3 is a potent proprietary formulation of eight strains of live lactic acid bacteria. Because it needs refrigeration, Sigma-Tau has, up until recently, relied mainly on physicians who recommend it and send patients to the pharmacy to find it. “Oftentimes consumers who come looking for VSL#3 are unaware the product must be kept refrigerated and is behind the pharmacy counter. They first go to the probiotic shelf where they are confronted with numerous brands of probiotics, and they are confused by all the different options and can’t find VSL#3,” explains Mary Ocnean, group product director, Sigma-Tau Pharmaceuticals, Inc. “The introduction of pharmacy cards for VSL#3 will help overcome this hurdle, and alleviate any disconnect between physicians recommending VSL#3 and the patients getting lost at the shelf when they don’t see the product.”

Ocnean continues, “Creating a positive experience for the consumer at the pharmacy shelf is one of our top priorities. The introduction of the VSL#3 shelf card will help retailers provide consumers an opportunity to purchase what they intended to purchase, and also help create awareness of a product some consumers didn’t know about.” Select pharmacies nationwide have already begun to roll out the VSL#3 branded shelf cards and will continue through 2014.

Another effort to grow awareness of VSL#3 amongst consumers is the brand’s new Facebook page to be launched in 2014. According to Ocnean, “The new Facebook page will offer consumers an opportunity to connect with others interested in probiotics and IBS or ulcerative colitis, to get dietary and lifestyle tips from healthcare experts and receive special offers and promotions. It’s a great way for us to share with consumers what is going on with the brand.”

About VSL#3:
All forms of VSL#3® are medical foods and must be used under medical supervision. VSL#3 is manufactured by Sigma-Tau Pharmaceuticals, Inc. and all forms are available behind the pharmacy counter at independent pharmacies, drug stores and mass market retailers nationwide and at http://www.vsl3.com. There are four formulations of VSL#3 products:
VSL#3 Double Strength - the most potent at 900 billion bacteria per packet, is available by prescription
VSL#3 Regular powder packets containing 450 billion bacteria (SRP: $87.72),
VSL#3 JUNIOR containing 225 billion bacteria (SRP: $54.78) and
VSL#3 capsules containing 112.5 billion bacteria (SRP: $53.00). Each proprietary formulation requires refrigeration to preserve its potency of live bacteria. Consumers can visit http://www.vsl3.com for more information or to purchase the product online.

Read the full story at http://www.prweb.com/releases/2014/08/prweb12077163.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. Probiotic Products May Prevent Antibiotic-Linked Diarrhea
2. New VSL#3® JUNIOR probiotic for children now available
3. Gene-Tweaked Tomatoes, Probiotics Aim to Lower Your Cholesterol
4. Probiotic Action Issues a Response to an Article on Medical News Today About Synthetic Skin Research
5. Probiotic Action Releases a Statement in Regards to a Recent Miami Herald Article on Minimizing Scars
6. Probiotic Action Responds an Article on ‘Skin Care Coaches’
7. Probiotic Action Responds to an Article Discussing the Health Benefits of Probiotics
8. Probiotic Action Responds to an Article Which Reports Alcohol Intake in Relation to Skin Health
9. Probiotic Action Spokesperson Reacts to New Treatments Being Developed for Teen Acne
10. MXI Corp; Xocai Healthy Chocolate Introduces, XoBiotic Squares, A Dark Chocolate With Probiotics, Designed To Maintain A Healthy Intestinal Balance
11. Probiotic Action Responds to Article Answering Common Questions About Acne
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/18/2017)... Hills, California (PRWEB) , ... February 17, 2017 ... ... info@drvallecillos.com , drvallecillos.com , Beverly Hills plastic surgeon Dr. ... subcutaneous fat cells. , Dr. Vallecillos says, "Traditionally, plastic surgery has been centered ...
(Date:2/18/2017)... , ... February 18, 2017 , ... ... provides the latest information and contact points to easily connect elderly veterans of ... assisted living, and elder-care funding. It also conveys material on this year's increase ...
(Date:2/17/2017)... ... February 17, 2017 , ... The Alliance ... change designed to further positively impact the health and wellness of our community ... considered it our duty to seriously consider releasing our assets beyond our 5% ...
(Date:2/17/2017)... ... February 17, 2017 , ... ... **An FDAnews Webinar**, Feb. 22, 2017 — 1:30 p.m. – 2:30 p.m. ... manufacturers should be asking before selecting an FDA approval pathway? , How ...
(Date:2/17/2017)... WA (PRWEB) , ... February 17, 2017 , ... ... management organizations, has been named a finalist in the 8th Annual DecisionHealth Platinum ... America's healthcare delivery system. Qualis Health’s work is recognized across multiple award categories, ...
Breaking Medicine News(10 mins):
(Date:2/17/2017)... Feb. 17, 2017  BioDigital, Inc., creators of ... of their 3D body mapping technology with eClinicalWorks, ... new integration will be used to capture and ... of the human body. BioDigital pilots show using ... while also increasing the precision of clinical annotations ...
(Date:2/16/2017)... -- Absorption Systems, a global leader in nonclinical testing ... announce that its Chief Operating Officer, Sid Bhoopathy ... the 2017 Executive Management Award. The award is sponsored ... for their creative management vision, leadership philosophy, innovative strategy ... is on March 8, 2017 at the Ballroom at ...
(Date:2/16/2017)... 2017 DaVita Inc. (NYSE: DVA ) ... 31, 2016. Net income attributable to DaVita ... was $158 million, or $0.80 per share and $880 million, ... income attributable to DaVita Inc. for the quarter and year ... was $192 million, or $0.98 per share, and $789 million, ...
Breaking Medicine Technology: